RxDoctor Payments Data

Ryan Pollina, MD

Interventional Pain Medicine · Saint Clair Shores, MINPI 1255635405

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $113,356 of the $144,493 with a category attached, or 78.5%. 16 manufacturers reported payments, led by Stimwave Technologies Incorporated at 51.1% of the total. Reporting peaked in 2023 at $35,456 and has fallen 64.4% since, to $12,608 in 2025. Among interventional pain medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$144,493in general payments, 2019–2025

Across 217 payments — averaging $665.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stimwave Technologies Incorporated$74K
  • Curonix LLC$66K
  • Vertiflex, Inc.$2K
  • Nevro Corp.$2K
  • Boston Scientific$792
  • Vertos Medical, Inc.$189
  • plus $522 from 10 others
$7,200in research payments, 2019–2025

Across 1 payment — averaging $7200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stimwave Technologies Incorporated$7K

What the payments were for

  • Consulting fees$113,35678%
  • Speaking & faculty fees$1,0001%
  • Travel & lodging$20,61714%
  • Food & beverage$6,3734%
  • Gifts$2390%
  • Entertainment$2,9072%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$144,493 in reported general payments places this provider in the 95th percentile of 88 interventional pain medicine providers in Michigan.

See all interventional pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$237,132
Medicare patients
396
Services billed
3,872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen684$13,023
OxycontinOxycodone Hcl24$9,639
Buprenorphine31$8,541
Xtampza ErOxycodone Myristate16$8,168
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl39$6,971
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen214$3,293
Gabapentin296$3,250
Pregabalin169$2,719
Lidocaine41$2,642
Oxycodone Hcl89$2,574
Methocarbamol100$1,323
Naloxone Hcl18$1,316
Baclofen89$1,173
Morphine Sulfate ErMorphine Sulfate59$1,127
Celecoxib59$1,067

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Saint Clair Shores

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →